Clinical Trial Update: Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 2, Phase 3]

View source ↗

Summary

This entry describes a Phase 2/3 clinical trial evaluating combination chemotherapy with or without whole-body hyperthermia in patients with recurrent ovarian c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2, Phase 3 | Status: UNKNOWN